A Study of r-PA Treating Patients With Acute Ischemic Stroke
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of recombinant human tissue
plasminogen kinase derivatives for injection and alteplase in the treatment of patients with
acute ischemic stroke within 4.5 hours.